» Articles » PMID: 26473364

Shigella Effector OspB Activates MTORC1 in a Manner That Depends on IQGAP1 and Promotes Cell Proliferation

Overview
Journal PLoS Pathog
Specialty Microbiology
Date 2015 Oct 17
PMID 26473364
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

The intracellular bacterial pathogen Shigella infects and spreads through the human intestinal epithelium. Effector proteins delivered by Shigella into cells promote infection by modulating diverse host functions. We demonstrate that the effector protein OspB interacts directly with the scaffolding protein IQGAP1, and that the absence of either OspB or IQGAP1 during infection leads to larger areas of S. flexneri spread through cell monolayers. We show that the effect on the area of bacterial spread is due to OspB triggering increased cell proliferation at the periphery of infected foci, thereby replacing some of the cells that die within infected foci and restricting the area of bacterial spread. We demonstrate that OspB enhancement of cell proliferation results from activation of mTORC1, a master regulator of cell growth, and is blocked by the mTORC1-specific inhibitor rapamycin. OspB activation of mTORC1, and its effects on cell proliferation and bacterial spread, depends on IQGAP1. Our results identify OspB as a regulator of mTORC1 and mTORC1-dependent cell proliferation early during S. flexneri infection and establish a role for IQGAP1 in mTORC1 signaling. They also raise the possibility that IQGAP1 serves as a scaffold for the assembly of an OspB-mTORC1 signaling complex.

Citing Articles

Endothelial Mechanistic Target of Rapamycin Activation with Different Strains of : Possible Role in Rickettsial Pathogenesis.

Sahni A, Alsing J, Narra H, Montini M, Zafar Y, Sahni S Microorganisms. 2024; 12(2).

PMID: 38399700 PMC: 10892065. DOI: 10.3390/microorganisms12020296.


Identification of Renal Transplantation Rejection Biomarkers in Blood Using the Systems Biology Approach.

Saberi F, Dehghan Z, Noori E, Zali H Iran Biomed J. 2024; 27(6):375-87.

PMID: 38224029 PMC: 10826908. DOI: 10.52547/ibj.3871.


Prediction model of poorly differentiated colorectal cancer (CRC) based on gut bacteria.

Qi Z, Zhibo Z, Jing Z, Zhanbo Q, Shugao H, Weili J BMC Microbiol. 2022; 22(1):312.

PMID: 36539710 PMC: 9764708. DOI: 10.1186/s12866-022-02712-w.


Molecular mechanisms of Shigella effector proteins: a common pathogen among diarrheic pediatric population.

Nasser A, Mosadegh M, Azimi T, Shariati A Mol Cell Pediatr. 2022; 9(1):12.

PMID: 35718793 PMC: 9207015. DOI: 10.1186/s40348-022-00145-z.


The Spp. Type III Effector Protein OspB Is a Cysteine Protease.

Wood T, Westervelt K, Yoon J, Eshleman H, Levy R, Burnes H mBio. 2022; 13(3):e0127022.

PMID: 35638611 PMC: 9239218. DOI: 10.1128/mbio.01270-22.


References
1.
Roy M, Li Z, Sacks D . IQGAP1 is a scaffold for mitogen-activated protein kinase signaling. Mol Cell Biol. 2005; 25(18):7940-52. PMC: 1234344. DOI: 10.1128/MCB.25.18.7940-7952.2005. View

2.
Miao E, Mao D, Yudkovsky N, Bonneau R, Lorang C, Warren S . Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome. Proc Natl Acad Sci U S A. 2010; 107(7):3076-80. PMC: 2840275. DOI: 10.1073/pnas.0913087107. View

3.
Chung L, Philip N, Schmidt V, Koller A, Strowig T, Flavell R . IQGAP1 is important for activation of caspase-1 in macrophages and is targeted by Yersinia pestis type III effector YopM. mBio. 2014; 5(4):e01402-14. PMC: 4161239. DOI: 10.1128/mBio.01402-14. View

4.
Maurelli A, Blackmon B, Curtiss 3rd R . Loss of pigmentation in Shigella flexneri 2a is correlated with loss of virulence and virulence-associated plasmid. Infect Immun. 1984; 43(1):397-401. PMC: 263440. DOI: 10.1128/iai.43.1.397-401.1984. View

5.
Chen F, Zhu H, Zhou L, Wu S, Wang J, Chen Z . IQGAP1 is overexpressed in hepatocellular carcinoma and promotes cell proliferation by Akt activation. Exp Mol Med. 2010; 42(7):477-83. PMC: 2912475. DOI: 10.3858/emm.2010.42.7.049. View